About Pathway Diagnostics
Pathway Diagnostics is a company based in Malibu (United States) founded in 2002 was acquired by Quest Diagnostics in December 2008. Pathway Diagnostics operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
- Headquarter Malibu, United States
- SectorsHealthcare
- Website pathwaydx.com
- Social LinkedIn
- Acquired by Quest Diagnostics (Dec 2008)
- Legal Name Pathway Diagnostics Corp
- Latest Funding Round$5.67M (USD), Debt – Convertible
Aug 2007
- InvestorsQuest Diagnostics
& 1 more
- Acquired byQuest Diagnostics
(Dec 2008)
Funding Insights of Pathway Diagnostics
- Total Rounds 2
- Last Round Debt – Convertible — $5.67M
- Investors Count 1
All 2 funding rounds of Pathway Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2007 | $5.67M | Debt – Convertible | – | – | – |
| Nov 2002 | – | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Pathway Diagnostics
Pathway Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics and Bay City Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage-agnostic investments in US life-sciences sectors are managed. | – | baycitycapital.com | San Francisco, United States | |
Integrated diagnostic and IT services are provided to healthcare organizations. | 1967 | questdiagnostics.com | Madison, United States |
Investor details for Pathway Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pathway Diagnostics
4 dated milestones of Pathway Diagnostics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Pathway Diagnostics is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Convertible, of $5.7M.
- Exit Acquired by Quest Diagnostics.
Competitors of Pathway Diagnostics
Pathway Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ribolia.com | 2007 | Suzhou, China | $200.79M | – | Nucleic acid drugs are developed via RNA interference technology. | |
| pathoquest.com | 2010 | Paris, France | $9.99M | – | Next-generation sequencing is provided for microbiology testing applications. | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | – | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | |
| chembio.com | 1986 | Medford, United States | – | 213 | Proprietary immunoassay platform is utilized for infectious disease diagnostics. | |
| senzo.com | 2013 | San Francisco, United States | $9.6M | 13 | Point-of-care diagnostic devices for infectious diseases are developed. | |
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. | |
| daktaridx.com | 2008 | Boston, United States | $73.42M | 23 | Point of care diagnostic platform and data management system | |
| e25bio.com | 2018 | Cambridge, United States | $4.8M | 5 | Diagnostic platform for disease detection and mapping is provided. | |
| matridx.com | 2019 | Hangzhou, China | – | – | Sequencing-based platform for microorganism detection in patients is developed. |
Detailed competitors of Pathway Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Pathway Diagnostics
10 companies that operate in the same segment as Pathway Diagnostics (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pathway Diagnostics
Pathway Diagnostics was founded in 2002.
Pathway Diagnostics is headquartered in Malibu, United States. It is registered at Malibu, California, United States.
Founded in 2002 in Malibu, United States, Pathway Diagnostics operated in the biotechnology sector. A biomarker discovery platform was utilized to identify novel disease-related biomarkers, which were licensed to biopharma companies. An internal pipeline of diagnostic assays was also advanced, including the flagship SensiTrop II HIV co-receptor assay for patient stratification via molecular hybridization. The company was acquired by Quest Diagnostics in December 2008 for an undisclosed amount.
Pathway Diagnostics's top competitors include Souzhou Ribo Life Science, Chembio and Quantalife.
Pathway Diagnostics has 2 investors. Key investors include Quest Diagnostics, and Bay City Capital.
Pathway Diagnostics operates through Pathway Diagnostics Corp.
Yes. Pathway Diagnostics was acquired by Quest Diagnostics in December 2008.